|Mr. Jonathan J. Mazelsky||Pres, CEO & Director||3.07M||12.86M||1961|
|Mr. Brian P. McKeon||CFO, Exec. VP & Treasurer||1.43M||26.11M||1962|
|Mr. James F. Polewaczyk||Exec. VP & Chief Commercial Officer||1.19M||5.61M||1964|
|Mr. Michael J. Lane||Exec. VP and GM of Reference Laboratories & Information Technology||1.19M||4.05M||1968|
|Dr. Tina Hunt P.E., Ph.D.||Exec. VP and GM - Point of Care Diagnostics & Worldwide Operations||1.18M||946.84k||1968|
|Mr. John Hart||Sr. VP of Worldwide Operations||N/A||N/A||N/A|
|Mr. Jeffery D. Chadbourne||Sr. Director of Accounting & Financial Reporting||N/A||N/A||1976|
|Dr. Martin Smith Ph.D.||Exec. VP & CTO||N/A||N/A||1968|
|Mr. Ken Grady||Sr. VP & Chief Information Officer||N/A||N/A||N/A|
|Ms. Sharon E. Underberg||Exec. VP, Gen. Counsel, & Corp. Sec.||N/A||N/A||1961|
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
IDEXX Laboratories, Inc.’s ISS Governance QualityScore as of May 1, 2022 is 5. The pillar scores are Audit: 7; Board: 1; Shareholder Rights: 8; Compensation: 3.